BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30381896)

  • 21. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer.
    Giebel S; Boratyn-Nowicka A; Karabon L; Jedynak A; Pamula-Pilat J; Tecza K; Kula D; Kowal M; Frydecka I; Grzybowska E
    Hum Immunol; 2014 Jun; 75(6):508-13. PubMed ID: 24755350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.
    Keating SE; Ní Chorcora C; Dring MM; Stallings RL; O'Meara A; Gardiner CM
    Tissue Antigens; 2015 Sep; 86(3):172-7. PubMed ID: 26202659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C.
    Moradi S; Stankovic S; O'Connor GM; Pymm P; MacLachlan BJ; Faoro C; Retière C; Sullivan LC; Saunders PM; Widjaja J; Cox-Livingstone S; Rossjohn J; Brooks AG; Vivian JP
    Nat Commun; 2021 Apr; 12(1):2173. PubMed ID: 33846289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Killer cell immunoglobulin-like receptor (KIR) genes in systemic sclerosis.
    Salim PH; Jobim M; Bredemeier M; Chies JA; Schlottfeldt J; Brenol JC; Jobim LF; Xavier RM
    Clin Exp Immunol; 2010 Jun; 160(3):325-30. PubMed ID: 20082621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.
    Moesta AK; Norman PJ; Yawata M; Yawata N; Gleimer M; Parham P
    J Immunol; 2008 Mar; 180(6):3969-79. PubMed ID: 18322206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition.
    Schönberg K; Sribar M; Enczmann J; Fischer JC; Uhrberg M
    Blood; 2011 Jan; 117(1):98-107. PubMed ID: 20935255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function.
    Foley B; Cooley S; Verneris MR; Pitt M; Curtsinger J; Luo X; Lopez-Vergès S; Lanier LL; Weisdorf D; Miller JS
    Blood; 2012 Mar; 119(11):2665-74. PubMed ID: 22180440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
    Guo KY; Mei JZ; Yao KT
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Killer Cell Immunoglobulin-like Receptors and Their HLA Ligands are Related with the Immunopathology of Chagas Disease.
    Ayo CM; Reis PG; Dalalio MM; Visentainer JE; Oliveira Cde F; de Araújo SM; de Oliveira Marques DS; Sell AM
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003753. PubMed ID: 25978047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human NK cells licensed by killer Ig receptor genes have an altered cytokine program that modifies CD4+ T cell function.
    Lin L; Ma C; Wei B; Aziz N; Rajalingam R; Yusung S; Erlich HA; Trachtenberg EA; Targan SR; McGovern DP; Heath JR; Braun J
    J Immunol; 2014 Jul; 193(2):940-9. PubMed ID: 24935928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide antagonism as a mechanism for NK cell activation.
    Fadda L; Borhis G; Ahmed P; Cheent K; Pageon SV; Cazaly A; Stathopoulos S; Middleton D; Mulder A; Claas FH; Elliott T; Davis DM; Purbhoo MA; Khakoo SI
    Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10160-5. PubMed ID: 20439706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KIR2DS2 Expression Identifies NK Cells With Enhanced Anticancer Activity.
    Blunt MD; Vallejo Pulido A; Fisher JG; Graham LV; Doyle ADP; Fulton R; Carter MJ; Polak M; Johnson PWM; Cragg MS; Forconi F; Khakoo SI
    J Immunol; 2022 Jul; 209(2):379-390. PubMed ID: 35768150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural killer cell activity and frequency of killer cell immunoglobulin-like receptors in children with different forms of juvenile idiopathic arthritis.
    Zhou J; Tang X; Ding Y; An Y; Zhao X
    Pediatr Allergy Immunol; 2013 Nov; 24(7):691-6. PubMed ID: 24112428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer.
    Cornillet M; Jansson H; Schaffer M; Hertwig L; Berglin L; Zimmer CL; Johansson H; Ellis E; Isaksson B; Gonzalez-Galarza FF; Middleton D; Malmberg KJ; Sparrelid E; Björkström NK
    Gastroenterology; 2019 Oct; 157(4):1067-1080.e9. PubMed ID: 31229495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of KIR2DL3 and KIR2DS2 natural killer receptors in exercise.
    Shleptsova VA; Grebenyuk ES; Khaustova SA; Obraztsova NP; Shkurnikov MY; Sakharov DA; Tonevitsky EA
    Bull Exp Biol Med; 2010 Nov; 149(6):755-8. PubMed ID: 21165439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KIR2DL2 and KIR2DS2 as genetic markers to the methotrexate response in rheumatoid arthritis patients.
    Velarde-de la Cruz EE; Sánchez-Hernández PE; Muñoz-Valle JF; Palafox-Sánchez CA; Ramírez-de Los Santos S; Graciano-Machuca O; García-Iglesias T; Montoya-Buelna M; Ramírez-Dueñas MG
    Immunopharmacol Immunotoxicol; 2016 Aug; 38(4):303-9. PubMed ID: 27251940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection.
    Charoudeh HN; Terszowski G; Czaja K; Gonzalez A; Schmitter K; Stern M
    Eur J Immunol; 2013 Feb; 43(2):480-7. PubMed ID: 23161492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KIR downregulation by IL-12/15/18 unleashes human NK cells from KIR/HLA-I inhibition and enhances killing of tumor cells.
    Ewen EM; Pahl JHW; Miller M; Watzl C; Cerwenka A
    Eur J Immunol; 2018 Feb; 48(2):355-365. PubMed ID: 29105756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.
    Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition.
    Winter CC; Gumperz JE; Parham P; Long EO; Wagtmann N
    J Immunol; 1998 Jul; 161(2):571-7. PubMed ID: 9670929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.